Evidence map›Paper›PMID 24399302›Full record

ArticleScientific reports2014

Mutation in ST6GALNAC5 identified in family with coronary artery disease.

Kolsoum InanlooRahatloo, Amir Farhang Zand Parsa, Klaus Huse, Paniz Rasooli, Saeid Davaran, Matthias Platzer, Marcel Kramer, Jian-Bing Fan, Casey Turk, Sasan Amini and 4 more

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
1.0field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 28 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Article
  6. Article
  7. Genetic analysis of early onset familial coronary artery diseases.Archives of medical sciences. Atherosclerotic diseases · 2019
    Article
  8. Article
  9. Article
  10. Sequences of 95 humanGenome research · 2017
    Article
  11. Review
  12. miRNA proxy approach reveals hidden functions of glycosylation.Proceedings of the National Academy of Sciences of the United States of America · 2015
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 5 institutions in 3 countries.

Kolsoum InanlooRahatloo1] School of Biology, College of Science, University of Tehran, Tehran, Iran [2] Genome Analysis, Leibniz Institute for Age Research-Fritz Lipmann Institute, Jena, Germany [3].
Amir Farhang Zand ParsaDepartment of Interventional Cardiology, Imam Khomeini Hospital, Tehran University of Medical Sciences, Tehran, Iran.
Klaus HuseGenome Analysis, Leibniz Institute for Age Research-Fritz Lipmann Institute, Jena, Germany.
Paniz RasooliSchool of Biology, College of Science, University of Tehran, Tehran, Iran.
Saeid DavaranTehran Heart Center, Tehran University of Medical Sciences, Tehran, Iran.
Matthias PlatzerGenome Analysis, Leibniz Institute for Age Research-Fritz Lipmann Institute, Jena, Germany.
Marcel KramerIntegrated Research and Treatment Center, Center for Sepsis Control and Care, Jena University Hospital, Jena, Germany.
Jian-Bing FanIllumina, San Diego, California, USA.
Casey TurkIllumina, San Diego, California, USA.
Sasan AminiIllumina, San Diego, California, USA.
Frank SteemersIllumina, San Diego, California, USA.
Kevin GundersonIllumina, San Diego, California, USA.
Mostafa RonaghiIllumina, San Diego, California, USA.
Elahe Elahi1] School of Biology, College of Science, University of Tehran, Tehran, Iran [2] Dept. of Biotechnology, College of Science, University of Tehran, Tehran, Iran.
Illumina (United States) · USUniversity of Tehran · IRLeibniz Institute on Aging - Fritz Lipmann Institute (FLI) · DETehran University of Medical Sciences · IRJena University Hospital · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

We aimed to identify the genetic cause of coronary artery disease (CAD) in an Iranian pedigree. Genetic linkage analysis identified three loci with an LOD score of 2.2. Twelve sequence variations identified by exome sequencing were tested for segregation with disease. A p.Val99Met causing mutation in ST6GALNAC5 was considered the likely cause of CAD. ST6GALNAC5 encodes sialyltransferase 7e. The variation affects a highly conserved amino acid, was absent in 800 controls, and was predicted to damage protein function. ST6GALNAC5 is positioned within loci previously linked to CAD-associated parameters. While hypercholesterolemia was a prominent feature in the family, clinical and genetic data suggest that this condition is not caused by the mutation in ST6GALNAC5. Sequencing of ST6GALNAC5 in 160 Iranian patients revealed a candidate causative stop-loss mutation in two other patients. The p.Val99Met and stop-loss mutations both caused increased sialyltransferase activity. Sequence data from combined Iranian and US controls and CAD affected individuals provided evidence consistent with potential role of ST6GALNAC5 in CAD. We conclude that ST6GALNAC5 mutations can cause CAD. There is substantial literature suggesting a relation between sialyltransferase and sialic acid levels and coronary disease. Our findings provide strong evidence for the existence of this relation.

Indexed as

MutationAdultCase-Control StudiesCoronary Artery DiseaseFemaleHumansMaleMiddle AgedPedigreeSialyltransferasesbrain-specific GD1alpha synthase, ST6GalNAc VSialyltransferases

Identifiers

PMID24399302
PMCPMC3884232
OpenAlexW2014642291

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.